VolitionRx - Vetting the pet health opportunity
While pets are increasingly being ‘humanized’, their healthcare has lagged advancements seen on the human side. With the COVID-19 pandemic...
105 Views
VolitionRx - Unravelling the web of NETs in sepsis
VolitionRx is a clinical diagnostics company with a different perspective on immunoassay technology for the detection and monitoring of severe...
669 Views
Video: VolitionRx - executive interview
VolitionRx is a multinational epigenetics company developing simple, easy-to-use, cost-effective blood tests to help diagnose a range of cancers...
399 Views
VolitionRx - New platform format; more proof-of-concept data
The last several months were eventful for VolitionRx. The publication of the first ever proof-of-concept data in haematological cancers was the...
621 Views
VolitionRx - Data with product-grade assays expected soon
According to the latest Q319 update, VolitionRx has made progress with proof-of-concept studies with its upgraded Nu.Q assays and expects to start...
818 Views